BRVT221
Non‑small‑cell lung cancer (I/O)
PreclinicalActive
Key Facts
About Biorevert
Biorevert uses network‑control systems biology to develop non‑lethal therapies that revert cancer and aging cells to healthy states.
View full company profileNon‑small‑cell lung cancer (I/O)
Biorevert uses network‑control systems biology to develop non‑lethal therapies that revert cancer and aging cells to healthy states.
View full company profile